Cargando…
The effect of early measles vaccination at 4.5 months of age on growth at 9 and 24 months of age in a randomized trial in Guinea-Bissau
BACKGROUND: Providing an early, additional measles vaccine (MV) at 4.5 months of age has been shown to reduce child mortality in low-income countries. We studied the effects on growth at 9 and 24 months of age. METHODS: A randomized controlled trial was conducted in Guinea-Bissau from 2003–2007 incl...
Autores principales: | Rasmussen, S. M., Biering-Sørensen, S., Byberg, S., Andersen, A., Bjerregaard-Andersen, M., Rodrigues, A., Benn, C. S., Martins, C. L., Aaby, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135799/ https://www.ncbi.nlm.nih.gov/pubmed/27912735 http://dx.doi.org/10.1186/s12887-016-0738-z |
Ejemplares similares
-
Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau
por: Do, Vu An, et al.
Publicado: (2017) -
A Randomized Trial of an Early Measles Vaccine at 4½ Months of Age in Guinea-Bissau: Sex-Differential Immunological Effects
por: Jensen, Kristoffer Jarlov, et al.
Publicado: (2014) -
Effect of early measles vaccine on pneumococcal colonization: A randomized trial from Guinea-Bissau
por: Hansen, Nadja Skadkær, et al.
Publicado: (2017) -
Correction: Effect of early measles vaccine on pneumococcal colonization: A randomized trial from Guinea-Bissau
por: Hansen, Nadja Skadkær, et al.
Publicado: (2019) -
BCG skin reactions by 2 months of age are associated with better survival in infancy: a prospective observational study from Guinea-Bissau
por: Schaltz-Buchholzer, Frederik, et al.
Publicado: (2020)